AOPEP and atherosclerosis: The assessment of lipoprotein subfractions and apolipoproteins (apo) represents a way to improve the cardiovascular risk prediction; in addition, they may enhance the accuracy of atherosclerosis detection, assist in treatment selection, and be useful for counselling first-degree relatives of patients with atherosclerosis [61].